FindTrial
Sign In

Study on the efficacy for the management of immune-related adverse events in patients treated with immune checkpoint inhibitor with the multidisciplinary teamwork (MDT) by a hierarchical model

Study on the efficacy for the management of immune-related adverse events in patients treated with immune checkpoint inhibitor with the multidisciplinary teamwork (MDT) by a hierarchical model

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035398
Enrollment
Unknown
Registered
2020-08-10
Start date
2020-09-01
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oncology

Interventions

case series:Nil

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18 or older, male or female. 2. Patients are confirmed with immune related adverse events (irAEs). 3. Sign informed consent.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
Adverse event related death rate;—

Secondary

MeasureTime frame
incidence of sequelae;recovery rate;—

Countries

China

Contacts

Public ContactYu Yiyi

Zhongshan Hospital, Fudan University

yu.yiyi@zs-hospital.sh.cn+86 13816730912

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026